EvE Bio and DrugBank Collaborate to Advance Drug Discovery with Comprehensive Pharmome Data
EvE Bio and DrugBank: A New Era in Drug Discovery
In a significant advancement for the drug discovery sector, EvE Bio and DrugBank have joined forces to integrate EvE Bio’s extensive pharmome-mapping dataset into the DrugBank intelligence platform. This collaboration aims to provide unprecedented access to a wealth of information regarding drug-target interactions, thereby enhancing research and development initiatives in the pharmaceutical arena.
The Pharmome Mapping
EvE Bio has established a reputation for being a pivotal player in the systematic mapping of the human pharmome, a comprehensive network of interactions between drugs and targets. Their latest dataset incorporates 385,572 rigorously validated drug-target interactions across 159 proven biological targets. This extensive mapping not only identifies primary drug targets but also highlights